Cargando…

Visible and subvisible particles in the BCG immunotherapeutic product ImmuCyst(®)

Bacille Calmette–Guerin, BCG, is a live attenuated bovine tubercle bacillus used for the treatment of non-muscle invasive bladder cancer. In this study, an Electrical Sensing Zone (ESZ) method was developed to measure the particle count and the size of BCG immunotherapeutic (BCG IT), or ImmuCyst® pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirkitadze, Marina, Remi, Elena, Bhandal, Kamaljit, Carpick, Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840432/
https://www.ncbi.nlm.nih.gov/pubmed/27158432
http://dx.doi.org/10.1016/j.csbj.2016.03.001
_version_ 1782428282967293952
author Kirkitadze, Marina
Remi, Elena
Bhandal, Kamaljit
Carpick, Bruce
author_facet Kirkitadze, Marina
Remi, Elena
Bhandal, Kamaljit
Carpick, Bruce
author_sort Kirkitadze, Marina
collection PubMed
description Bacille Calmette–Guerin, BCG, is a live attenuated bovine tubercle bacillus used for the treatment of non-muscle invasive bladder cancer. In this study, an Electrical Sensing Zone (ESZ) method was developed to measure the particle count and the size of BCG immunotherapeutic (BCG IT), or ImmuCyst® product using a Coulter Counter Multisizer 4® instrument. The focus of this study was to establish a baseline for reconstituted lyophilized BCG IT product using visible and sub-visible particle concentration and size distribution as reportable values. ESZ method was used to assess manufacturing process consistency using 20 production scale lots of BCG IT product. The results demonstrated that ESZ can be used to accumulate product and process knowledge of BCG IT.
format Online
Article
Text
id pubmed-4840432
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Research Network of Computational and Structural Biotechnology
record_format MEDLINE/PubMed
spelling pubmed-48404322016-05-06 Visible and subvisible particles in the BCG immunotherapeutic product ImmuCyst(®) Kirkitadze, Marina Remi, Elena Bhandal, Kamaljit Carpick, Bruce Comput Struct Biotechnol J Research Article Bacille Calmette–Guerin, BCG, is a live attenuated bovine tubercle bacillus used for the treatment of non-muscle invasive bladder cancer. In this study, an Electrical Sensing Zone (ESZ) method was developed to measure the particle count and the size of BCG immunotherapeutic (BCG IT), or ImmuCyst® product using a Coulter Counter Multisizer 4® instrument. The focus of this study was to establish a baseline for reconstituted lyophilized BCG IT product using visible and sub-visible particle concentration and size distribution as reportable values. ESZ method was used to assess manufacturing process consistency using 20 production scale lots of BCG IT product. The results demonstrated that ESZ can be used to accumulate product and process knowledge of BCG IT. Research Network of Computational and Structural Biotechnology 2016-04-06 /pmc/articles/PMC4840432/ /pubmed/27158432 http://dx.doi.org/10.1016/j.csbj.2016.03.001 Text en © 2016 Natrix Separations http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Article
Kirkitadze, Marina
Remi, Elena
Bhandal, Kamaljit
Carpick, Bruce
Visible and subvisible particles in the BCG immunotherapeutic product ImmuCyst(®)
title Visible and subvisible particles in the BCG immunotherapeutic product ImmuCyst(®)
title_full Visible and subvisible particles in the BCG immunotherapeutic product ImmuCyst(®)
title_fullStr Visible and subvisible particles in the BCG immunotherapeutic product ImmuCyst(®)
title_full_unstemmed Visible and subvisible particles in the BCG immunotherapeutic product ImmuCyst(®)
title_short Visible and subvisible particles in the BCG immunotherapeutic product ImmuCyst(®)
title_sort visible and subvisible particles in the bcg immunotherapeutic product immucyst(®)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840432/
https://www.ncbi.nlm.nih.gov/pubmed/27158432
http://dx.doi.org/10.1016/j.csbj.2016.03.001
work_keys_str_mv AT kirkitadzemarina visibleandsubvisibleparticlesinthebcgimmunotherapeuticproductimmucyst
AT remielena visibleandsubvisibleparticlesinthebcgimmunotherapeuticproductimmucyst
AT bhandalkamaljit visibleandsubvisibleparticlesinthebcgimmunotherapeuticproductimmucyst
AT carpickbruce visibleandsubvisibleparticlesinthebcgimmunotherapeuticproductimmucyst